how to approach hirschsprung disease · 2020. 3. 17. · hirschsprung disease c. rebiopsy d. other....
TRANSCRIPT
![Page 1: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/1.jpg)
How to Approach Hirschsprung Disease
Raj P. KapurSeattle Children’s &
University of Washington
![Page 2: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/2.jpg)
Objectives
1. Diagnosis (based on rectal biopsy)
2. Intra-operative consultation
3. Post-operative surgical pathology
RECOMMENDATIONS
![Page 3: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/3.jpg)
Clinical History• 3 d old male• Failed to pass meconium in the first 48h• Abdominal distension and vomiting
• Barium enema shows dilated sigmoid and narrow rectum (recto-sigmoid ratio <1)
![Page 4: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/4.jpg)
Suction Rectal Biopsy
![Page 5: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/5.jpg)
RECTAL BIOPSY-BASED DIAGNOSISOF HIRSCHSPRUNG DISEASE
X
![Page 6: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/6.jpg)
TOO LOW(False Positive)
X
TOO HIGH(False Negative)
![Page 7: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/7.jpg)
Suction Biopsies from Multiple LevelsLess likely that all biopsies will lack sufficient submucosa
Fewer inadequate biopsies due to sampling of anal or transitional mucosa
Mapping data- "reposition" low biopsies- very short-segment HSCR
R1: Advise surgeon to get biopsies from multiple levels in separate containers
![Page 8: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/8.jpg)
IN MOST CASES H&E IS SUFFICIENT
CALRETININ
+
++
Adequate Bx
No Ganglion Cell
Nerve Hypertrophy
ExperiencedPathologist
= DIAGNOSIS
![Page 9: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/9.jpg)
3 mm
ADEQUACY
R2: Routinely cut lots of sections and have a low threshold for more levels
![Page 10: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/10.jpg)
Hypertrophic Submucosal NervesMonforte-Munoz et al. (1998) Arch Pathol Lab Med 122:721-5
Experience
R3: Pay careful attention to submucosal nerve calibers
![Page 11: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/11.jpg)
Ancillary Diagnostic Methods• Experience varies (recognition of ganglion cells,
especially immature cells, requires practice)
• Some biopsies have borderline adequacy
• Not all biopsies of aganglionic rectum contain hypertrophic nerves
• Histological quality varies
• Tissue sampling to exclude ganglion cells and large nerves is cumbersome and costly
![Page 12: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/12.jpg)
![Page 13: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/13.jpg)
AChE (frozen) ChT (FFPE)
Agan
glio
nic
Gan
glio
nic
Kapur et alPediatr Dev Pathol 2017; 20:308-20
![Page 14: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/14.jpg)
RECOMMENDED APPROACH
controls
AgangGang
AgangGang
controls
patient patient
![Page 15: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/15.jpg)
Calretinin“2 cm”YOUR DIAGNOSIS?
A. Hirschsprung disease
B. Not Hirschsprung disease
C. RebiopsyD. Other
No ganglion cells
![Page 16: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/16.jpg)
![Page 17: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/17.jpg)
Intact Calretinin Innervation Aganglionic Rectal Biopsies
Calretinin-immunoreactive mucosal nerves are present in the proximal 1-to-2 cm of the
aganglionic segment in HD may be present in aganglionic biopsies from
the distal rectum of a patient with vssHD
![Page 18: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/18.jpg)
Intact Calretinin Innervation Aganglionic Rectal Biopsies
R3: Pay careful attention to
submucosal nerve calibers!
HypertrophicNerves
![Page 19: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/19.jpg)
Recommendations
• Routinely obtain biopsies from more than one site • Perform calretinin ihc on at least one biopsy from
every patient• Pay close attention to nerve hypertrophy, even if
ganglion cells are present• In some situations (e.g., vssHSCR), AChE
histochemistry or ChT ihc may be particularly helpful• Have low threshold for rebiopsy and/or full-thickness
biopsy, especially in older patients
![Page 20: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/20.jpg)
Intraoperative Consultation
![Page 21: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/21.jpg)
L-HSCR(13%)
C-HSCR(7%)
S-HSCR(80%)
INTRAOPERATIVE LEVELLING BIOPSYFinding Ganglionic Bowel
5-10 mmIkeda & Goto (1984) Ann Surg 199:400-5
![Page 22: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/22.jpg)
HANDLING AND INTERPRETATION OF LEVELLING BIOPSY
![Page 23: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/23.jpg)
![Page 24: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/24.jpg)
SP08-5984
![Page 25: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/25.jpg)
Orientation and location are important
![Page 26: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/26.jpg)
Myenteric Ganglion
![Page 27: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/27.jpg)
Set a high cytological threshold
![Page 28: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/28.jpg)
SP08-5984
Diff-Qwik Stain
![Page 29: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/29.jpg)
What do you advise the surgeon?
A. Do an appendectomy to exclude a skip area
B. Perform ileostomy or resection at this site
C. Obtain seromuscular biopsy of more proximal bowel to confirm ganglion cells are present
D. OtherGanglion cells are present
Levelling Biopsy
![Page 30: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/30.jpg)
![Page 31: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/31.jpg)
Partial Circumferential Aganglionosis
Myenteric Hypoganglionosis
Submucosal Nerve Hypertrophy
Pelvic Gang
TRANSITION ZONE
In short-segment HSCR, the TZ is typically <5cm
![Page 32: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/32.jpg)
INTRAOPERATIVE HISTOPATHOLOGYExcluding Transition Zone
Find ganglion cells andmake anastomosis at least 5 cm proximal to that point
Conduct frozen section examination of donut from proximal margin to assess circumferential distribution of ganglion cells and submucosal nerve hypertrophy
≥5 cm
![Page 33: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/33.jpg)
INTRAOPERATIVE HISTOPATHOLOGYExcluding Transition Zone
Exclude Features of Transition Zone:Partial Circumferential AganglionosisMyenteric HypoganglionosisSubmucosal Nerve Hypertrophy
![Page 34: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/34.jpg)
MYENTERIC HYPOGANGLIONOSIS
![Page 35: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/35.jpg)
SUBMUCOSAL NERVE HYPERTROPHY
Coe et al. 2012
≥2 submucosal nerves per high power field with
diameters ≥40 µm
![Page 36: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/36.jpg)
3-STEP APPROACH
1. Levelling biopsy to find ganglion cells (identify a site oral to the aganglionic segment)
2. Surgeon should perform resection at least 5 cm proximal to levelling biopsy with ganglion cells
3. Frozen section of proximal margin to exclude features of transition zone
(Repeat 2 and 3 as needed)
![Page 37: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/37.jpg)
HANDLING THE RESECTION SPECIMEN
![Page 38: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/38.jpg)
SYNOPTIC REPORTING
https://hematogones.com/surg-path/hirsch
![Page 39: How to Approach Hirschsprung Disease · 2020. 3. 17. · Hirschsprung disease C. Rebiopsy D. Other. No ganglion cells. Intact Calretinin Innervation Aganglionic Rectal Biopsies Calretinin-immunoreactive](https://reader035.vdocuments.mx/reader035/viewer/2022071514/613534abdfd10f4dd73c397f/html5/thumbnails/39.jpg)